Pnc Financial Services Group, Inc. Puma Biotechnology, Inc. Transaction History

Pnc Financial Services Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	BUY	$2.13 - $3.24 $261 - $398	123 New	123 $0
Q1 2020 May 08, 2020	SELL	$6.28 - $14.57 $464 - $1,078	-74 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$8.75 - $12.85 $1.04 Million - $1.53 Million	-119,390 Reduced 99.94%	74 $0
Q2 2019 Aug 09, 2019	SELL	$12.3 - $35.76 $395,100 - $1.15 Million	-32,122 Reduced 21.19%	119,464 $0
Q1 2019 May 10, 2019	BUY	$20.77 - $42.37 $3.15 Million - $6.42 Million	151,586 New	151,586 $0
Q2 2018 Aug 10, 2018	SELL	$48.3 - $68.25 $289 - $409	-6 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$93.85 - $132.45 $563 - $794	6	6 $0

102

29M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $138M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.